Medpace Holdings (MEDP) Enterprise Value (2015 - 2026)

Medpace Holdings has reported Enterprise Value for 12 years, with the latest figure at -$652.7 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 47.85% year-over-year to -$652.7 million; the trailing twelve-month figure through Mar 2026 stood at -$652.7 million (down 47.85% YoY), and the FY2025 full-year result was -$497.0 million, up 25.75% from the prior year.
• Enterprise Value for Q1 2026 stood at -$652.7 million, down from -$497.0 million in the prior quarter.
• The five-year high for Enterprise Value was -$28.3 million in Q4 2022, with the low at -$669.4 million in Q4 2024.
• Historically, Enterprise Value has averaged -$281.1 million across 5 years, with a median of -$245.4 million in 2023.
• Annual changes were most pronounced in 2022 — Enterprise Value jumped 93.87% — and 2024, when it sank 1205.37%.
• Medpace Holdings' Enterprise Value stood at -$28.3 million in 2022, then plunged by 768.38% to -$245.4 million in 2023, then sank by 172.74% to -$669.4 million in 2024, then increased by 25.75% to -$497.0 million in 2025, then plunged by 31.31% to -$652.7 million in 2026.
• The last three Enterprise Value figures came in at -$652.7 million (Q1 2026), -$497.0 million (Q4 2025), and -$285.4 million (Q3 2025), per Business Quant data.